An Lei, Zhang You-Zhi, Yu Neng-Jiang, Liu Xin-Min, Zhao Nan, Yuan Li, Chen Hong-Xia, Li Yun-Feng
Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1484-90. doi: 10.1016/j.pnpbp.2008.05.005. Epub 2008 May 15.
Xiaobuxin-Tang (XBXT), a traditional Chinese herbal decoction, has been used for the treatment of depressive disorders for centuries in China. Our previous studies have demonstrated that the total flavonoids (XBXT-2) isolated from the extract of XBXT reversed behavioral alterations and serotonergic dysfunctions in chronically stressed rats. Recently, accumulating studies have suggested the behavioral effects of chronic antidepressants treatment might be mediated by the stimulation of hippocampal neurogenesis. In present study, we explored the effect of XBXT-2 on hippocampal neurogenesis and neurotrophic signal pathway in chronically stressed rats. Our immunohistochemistry results showed that concomitant administration of XBXT-2 (25, 50 mg/kg, p.o., 28 days, the effective doses for behavioral responses) significantly increased hippocampal neurogenesis in chronically stressed rats. Four weeks after BrdU injection, result in double immunofluorescence labeling showed that some of the newly generated cells in hippocampus co-expressed with NSE or GFAP, markers for neurons or astrocytes, respectively. Furthermore, XBXT-2 treatment reserved stress-induced decrease of hippocampal BDNF and pCREB (Ser133) expression, two important factors which were closely related to hippocampal neurogenesis. As a positive control drug, imipramine (10 mg/kg, p.o.) exerted same effects. In conclusion, the increase of neurogenesis, as well as expression of BDNF and pCREB in hippocampus may be one of the molecular and cellular mechanisms underlying the antidepressant action of XBXT-2.
逍遥散(XBXT)是一种传统的中药汤剂,在中国已有数百年用于治疗抑郁症的历史。我们之前的研究表明,从逍遥散提取物中分离出的总黄酮(XBXT - 2)可逆转慢性应激大鼠的行为改变和5-羟色胺能功能障碍。最近,越来越多的研究表明,慢性抗抑郁药治疗的行为效应可能是通过刺激海马神经发生介导的。在本研究中,我们探讨了XBXT - 2对慢性应激大鼠海马神经发生和神经营养信号通路的影响。我们的免疫组织化学结果显示,同时给予XBXT - 2(25、50mg/kg,口服,28天,行为反应的有效剂量)可显著增加慢性应激大鼠的海马神经发生。注射BrdU四周后,双重免疫荧光标记结果显示,海马中一些新生成的细胞分别与神经元或星形胶质细胞的标志物NSE或GFAP共表达。此外,XBXT - 2治疗可逆转应激诱导的海马BDNF和pCREB(Ser133)表达降低,这两个重要因素与海马神经发生密切相关。作为阳性对照药物,丙咪嗪(10mg/kg,口服)也有相同作用。总之,神经发生增加以及海马中BDNF和pCREB的表达可能是XBXT - 2抗抑郁作用的分子和细胞机制之一。